Violin Jonathan's Form 4 filing
Viridian Therapeutics, Inc. (VRDN) · filed Apr 5, 2022
- Accession no.
- 0000899243-22-013858
- Filed
- Apr 5, 2022
- Trade date
- Apr 1-4, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $567.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Violin JonathanCIK 0001730615 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Common Stock | SSaleDisposed | −26,400 | $18.92 | −$499,488 | 544,505 | Direct | |
| Apr 4, 2022 | Common Stock | SSaleDisposed | −3,600 | $18.93 | −$68,148 | 540,905 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.